News
Denali slides after ALS drug flunks clinical test Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback